Infinity pharmaceuticals, inc. (INFI)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and Cash Equivalents, at Carrying Value

30,485

22,260

21,588

42,625

52,947

48,616

32,216

49,165

30,575

34,607

33,580

66,197

75,429

74,060

98,507

122,351

113,755

188,170

137,284

134,607

223,045

307,405

321,257

85,516

54,971

68,114

53,478

55,248

101,142

175,742

52,917

19,651

23,462

24,197

23,091

17,461

20,416

Available-for-sale securities

19,863

20,184

30,401

20,374

17,584

9,975

9,953

0

17,239

23,002

21,995

0

0

18,004

13,791

24,041

79,213

57,061

25,677

64,868

10,008

25,321

57,745

55,642

116,560

145,772

196,825

221,432

201,426

150,276

135,853

84,261

80,832

91,081

51,515

64,176

79,804

Receivable (note 8)

-

-

-

-

-

-

22,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

0

515

500

1,152

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due from AbbVie

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

130,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan commitment asset, net (note 10)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

647

1,681

7,719

10,655

-

-

-

-

-

-

-

-

-

-

-

-

Unbilled accounts receivable from Purdue entities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

237

218

715

69

-

Prepaid Expense and Other Assets, Current

2,677

2,137

2,395

1,974

3,641

1,227

961

1,273

1,248

777

8,364

2,065

4,381

8,444

11,178

11,085

15,073

9,466

7,354

8,992

6,317

11,195

10,032

11,310

12,064

11,055

4,701

5,146

5,267

3,731

3,673

3,368

4,123

2,485

3,110

3,178

2,907

Total current assets

53,025

44,581

54,384

64,973

74,172

59,818

65,130

50,438

49,062

58,386

63,939

68,777

80,310

101,660

123,476

157,477

208,041

254,697

300,315

208,467

239,370

344,568

390,715

160,187

194,250

224,941

255,004

281,826

307,835

329,749

192,443

107,280

108,654

117,981

78,433

84,885

103,128

Property and equipment, net

2,071

2,186

2,274

955

51

28

58

103

156

219

309

22,040

22,732

23,424

24,451

25,719

27,918

28,240

28,077

27,392

22,720

18,970

2,982

3,361

3,748

4,010

4,089

4,179

3,925

4,079

3,871

3,939

4,372

4,582

4,327

4,621

5,147

Loan commitment asset from Purdue entities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,989

13,422

14,288

Long-term available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

508

519

533

545

565

582

554

557

580

617

636

647

648

659

674

670

736

Restricted Cash and Cash Equivalents, Noncurrent

315

315

315

315

-

0

-

-

-

-

0

0

530

530

1,182

1,182

1,681

1,681

1,681

1,680

1,680

1,680

2,162

1,131

1,130

1,130

1,129

1,129

1,128

1,128

1,127

1,127

1,126

1,125

1,124

1,124

1,122

Operating lease right-of-use assets

1,661

1,717

1,726

1,782

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term receivable (note 11)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,453

2,525

503

1,821

2,806

3,006

3,006

3,006

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

16

215

409

413

522

369

725

725

748

748

23

28

35

41

340

387

2,357

2,382

347

333

358

401

433

361

88

47

36

32

25

87

114

56

124

143

155

79

141

Total assets

57,088

49,014

59,108

68,438

74,745

60,215

65,913

51,266

49,966

59,353

64,271

90,845

103,607

125,655

151,902

187,290

240,500

288,821

333,226

240,878

267,642

369,144

396,825

165,585

199,781

230,710

260,812

287,723

313,493

335,660

198,191

113,049

114,924

124,490

97,704

104,804

124,565

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

1,361

1,621

1,505

1,054

1,685

1,197

491

767

300

459

354

581

733

2,413

4,786

12,741

9,097

9,628

11,214

7,830

5,697

5,947

11,041

3,923

5,852

6,375

5,010

4,702

2,940

2,148

4,892

7,609

6,329

5,952

2,759

2,520

2,606

Accrued Liabilities And Other Current Liabilities

7,102

8,077

7,244

7,136

5,774

6,521

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued Liabilities, Current

-

-

-

-

-

-

5,614

4,912

4,242

5,136

4,517

9,899

9,394

21,008

20,679

31,102

22,952

24,604

22,890

19,408

12,564

17,768

18,764

16,022

13,763

9,164

11,913

9,583

7,839

10,059

12,966

15,488

14,321

18,819

18,461

14,063

20,363

Convertible Debt, Current

-

-

-

-

-

-

0

0

0

6,000

6,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due to Takeda

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,667

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due to Takeda, current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,614

6,561

6,508

6,667

6,613

6,561

6,508

6,456

-

-

-

-

-

-

-

Deferred revenue, current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

34,301

35,408

39,799

30,590

26,060

24,495

21,994

-

-

-

-

-

-

-

-

13,990

7,585

4,215

4,214

4,569

4,780

Financing obligation, current (note 7)

-

-

-

-

-

-

-

-

-

-

0

456

449

442

435

429

422

416

409

403

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

8,463

9,698

8,749

8,190

7,459

7,718

6,105

5,679

4,542

11,595

10,871

10,936

10,576

23,863

25,900

44,272

66,772

70,056

74,312

58,231

44,321

54,877

58,413

26,506

26,123

22,206

23,536

20,846

17,287

18,663

17,858

37,087

28,235

28,986

25,435

21,153

27,750

Liability For Sale of Future Royalties, Noncurrent

28,926

29,626

29,751

28,797

27,846

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability related to sale of future royalties to a related party, net (note 10)

19,800

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability, less current portion

1,808

1,926

1,955

1,849

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due to Takeda, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,456

6,405

6,353

6,302

6,252

-

-

-

-

-

-

-

Long-term debt due to Purdue entities, net of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38,927

-

37,553

-

-

-

Long-term debt due to Purdue entities, net of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38,234

-

-

-

-

Deferred revenue, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

87,383

95,531

100,218

70,171

79,581

85,510

92,367

-

-

-

-

-

-

-

-

40,040

41,093

42,147

43,200

44,254

46,361

Deferred rent, less current portion (note 7)

-

-

-

-

-

-

-

-

-

-

0

186

185

183

4,527

4,667

4,808

4,632

5,041

4,875

4,082

3,375

-

-

-

458

-

-

-

-

-

-

-

-

-

-

-

Financing obligation, less current portion (note 7)

-

-

-

-

-

-

-

-

-

-

0

20,799

19,034

19,149

19,262

19,373

19,483

19,591

19,697

19,802

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Construction liability (note 12)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,082

15,456

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

343

38

38

34

35

38

36

31

27

28

26

22

23

6

92

147

408

454

347

538

497

454

529

594

605

315

611

618

539

540

606

387

399

371

996

1,017

970

Total liabilities

59,340

41,288

40,493

38,870

35,340

7,756

6,141

5,710

4,569

11,623

10,897

31,943

29,818

43,201

49,781

68,459

178,854

190,264

199,615

153,617

146,563

159,672

151,309

27,100

26,728

29,435

30,552

27,817

24,128

25,455

18,464

116,441

107,961

109,057

69,632

66,424

75,082

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred Stock, $0.001 par value; 1,000,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common Stock, $0.001 par value; 100,000,000 shares authorized; 57,433,598 and 57,077,550 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

57

57

57

57

57

57

57

57

54

51

51

50

50

50

50

50

49

49

49

49

49

49

49

48

48

48

48

48

48

48

39

27

27

27

26

26

26

Additional paid-in capital

734,290

733,486

732,980

732,515

731,861

731,178

730,272

729,432

722,324

715,213

713,548

711,970

709,903

708,096

704,829

702,040

697,809

694,051

689,961

686,051

681,434

676,521

672,206

668,361

664,912

650,867

646,919

642,744

639,508

633,039

455,610

290,949

286,634

284,436

283,019

281,356

278,412

Accumulated deficit

-736,715

-725,829

-714,447

-703,030

-692,516

-678,772

-670,552

-683,933

-676,970

-667,519

-660,223

-653,118

-636,164

-625,689

-602,759

-583,261

-636,252

-595,588

-556,398

-598,942

-560,514

-467,212

-426,870

-530,086

-492,062

-449,796

-416,871

-382,933

-350,342

-323,016

-276,031

-294,434

-279,774

-269,052

-254,990

-243,046

-229,009

Accumulated other comprehensive income

116

12

25

26

3

-4

-5

0

-11

-15

-2

0

0

-3

1

2

40

45

-1

103

110

114

131

162

155

156

164

47

151

134

109

66

76

22

16

42

53

Stockholders' Equity Attributable to Parent

-2,252

7,726

18,615

29,568

39,405

52,459

59,772

45,556

45,397

47,730

53,374

58,902

73,789

82,454

102,121

118,831

61,646

98,557

133,611

87,261

121,079

209,472

245,516

138,485

173,053

201,275

230,260

259,906

289,365

310,205

179,727

-3,392

6,963

15,433

28,071

38,380

49,483

Total liabilities and stockholders’ equity (deficit)

57,088

49,014

59,108

68,438

74,745

60,215

65,913

51,266

49,966

59,353

64,271

90,845

103,607

125,655

151,902

187,290

240,500

288,821

333,226

240,878

267,642

369,144

396,825

165,585

199,781

230,710

260,812

287,723

313,493

335,660

198,191

113,049

114,924

124,490

97,704

104,804

124,565